AMLX

Amylyx Pharmaceuticals, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$14.95

Market Cap

$1.24B

Beta

-0.21

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-100.00%

EPS Growth (YoY)+65.54%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-9.94%

Debt / Equity0.02

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for AMLX.